Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial Assessing the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall, Incorporating Translationnal Research

NCT07507773 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT07507773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07507773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial Assessing the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall, Incorporating Translationnal Research
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Recruiting
Start date
July 21, 2026
Completion date
June 1, 2035
Enrollment
135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma (excluding gist), soft tissue sarcoma adult, soft tissue sarcoma of the limb, soft tissue sarcoma of the trunk and extremities